Frameshift mutations rank among the most disruptive changes that can happen to a gene. When one or two nucleotides are inserted into or deleted from a protein-coding stretch of DNA, the entire downstream reading frame shifts, scrambling the amino acid sequence and usually producing a premature stop signal that truncates the protein. Roughly one-third of all known human genetic diseases trace back to such premature stop signals, making frameshifts far more than a textbook curiosity. Their clinical footprint spans muscular dystrophies, hereditary cancers, neurodegenerative conditions, and, in a twist, some of the most promising new immunotherapy targets.
Why a Single Nucleotide Changes Everything
Cells read DNA in groups of three nucleotides at a time. Each triplet encodes one amino acid. Remove or add a single nucleotide and every triplet downstream gets redrawn: what was once a meaningful instruction becomes gibberish. A frameshift can shift the reading window by one or two positions in either direction, and either shift is enough to produce an entirely new, nonfunctional chain of amino acids until the ribosome hits a stop codon that was never supposed to be there.1PeerJ. On the efficiency of the genetic code after frameshift mutations This is what separates frameshifts from point mutations, which swap one amino acid for another. A point mutation is like a typo in a single word; a frameshift is like removing a letter and then re-spacing the rest of the sentence so that every subsequent word is wrong.
That said, not every insertion or deletion causes a frameshift. If the number of inserted or deleted bases is divisible by three, the reading frame stays intact. The result is a protein with one or more amino acids added or removed, but the rest of the sequence reads normally. These in-frame insertions and deletions can still cause disease, though they tend to be less catastrophic than true frameshifts. Computational tools designed to evaluate such variants show they require different prediction methods from frameshifting ones, reflecting genuinely distinct biology.2PLOS Computational Biology. Pathogenicity and functional impact of non-frameshifting insertion/deletion variation in the human genome
How Frameshift Mutations Arise
The most common natural source of frameshifts is replication slippage. When cells copy DNA, the machinery occasionally loses its grip at stretches of repetitive sequence. The polymerase enzyme pauses and then dissociates from the DNA strand; when it re-engages, it may line up one repeat unit off from where it left, adding or skipping a nucleotide or two.3PubMed Central. Replication slippage involves DNA polymerase pausing and dissociation Repetitive sequences are especially vulnerable, and even a simple two-base repeat can be enough to trigger the slip. One study showed that a human polymerase catalyzes this slippage in stretches as short as a dinucleotide repeat.4PubMed. To slip or skip, visualizing frameshift mutation dynamics for error-prone DNA polymerases
Cells have a built-in proofreading system called mismatch repair that catches many of these slippage errors after replication. The composition of the repeat matters: runs of certain bases are repaired more or less efficiently, affecting how often frameshifts accumulate at specific locations in the genome.5PubMed Central. Base composition of mononucleotide runs affects DNA polymerase slippage and removal of frameshift intermediates by mismatch repair in Saccharomyces cerevisiae When mismatch repair itself is defective, as it is in certain hereditary cancer syndromes, frameshift rates at repetitive sites skyrocket. This condition, called microsatellite instability, is a hallmark of some colorectal, endometrial, and stomach cancers and will come up again when we look at immunotherapy.
External agents can also push the rate of frameshifts higher. Chemical compounds called intercalators wedge themselves between the base pairs of the DNA double helix. The best-studied group, acridine derivatives, have been recognized as frameshift-causing agents for about sixty years.6PubMed Central. Half-Intercalation Stabilizes Slipped Mispairing and Explains Genome Vulnerability to Frameshift Mutagenesis by Endogenous “Molecular Bookmarks” They are potent frameshift mutagens in bacteria and bacteriophage, though their mutagenic effects in other organisms are more limited.7PubMed. Genotoxicity of non-covalent interactions: DNA intercalators These intercalators show preferences for certain sequence contexts, tending to cause frameshifts within runs of G:C base pairs.8Mutation Research – Fundamental and Molecular Mechanisms of Mutagenesis. Frameshift mutagenesis in Escherichia coli by reversible DNA intercalators: sequence specificity
The Cell’s Safety Net for Bad Transcripts
Because frameshifts almost always generate premature stop codons, the cell has a surveillance system tailored to deal with the resulting defective messenger RNA. This process, called nonsense-mediated mRNA decay, recognizes transcripts that stop translating too early and flags them for destruction before they can produce harmful truncated proteins. Nonsense and frameshift mutations that create premature stop codons account for about a third of all known human genetic diseases, giving this cleanup pathway an outsized role in health.9PubMed Central. Nonsense-mediated mRNA decay: inter-individual variability and human disease
This safety net is not perfect. Mutations near the very end of a gene can dodge the surveillance system entirely. Truncating variants in the last exon or so of a gene tend to escape decay because the cell’s machinery has no downstream signal telling it the stop came too early.10PubMed Central. Systematic analysis of variants escaping nonsense-mediated decay uncovers candidate Mendelian diseases These escapees can produce shortened proteins that may act in dominant-negative fashion, actively interfering with normal cell function rather than simply being absent. In some cases, even mutations that bioinformatic tools predict should trigger decay manage to eliminate the transcript through other mechanisms, as researchers found with certain frameshift mutations in the beta-globin gene.11PubMed Central. Two novel C-terminal frameshift mutations in the β-globin gene lead to rapid mRNA decay The efficiency of this decay process also varies from person to person, meaning the same frameshift mutation can produce different severity of disease in different individuals.
Duchenne and Becker Muscular Dystrophy
Perhaps the clearest illustration of how frameshifts drive disease comes from the dystrophin gene, one of the largest in the human genome. Deletions within this gene cause both Duchenne muscular dystrophy (DMD) and the milder Becker muscular dystrophy (BMD). The critical difference between the two often comes down to whether the deletion disrupts the reading frame. Deletions that shift the reading frame cause Duchenne: the resulting transcript is destroyed or produces a severely truncated, unstable protein, and muscle fibers progressively degenerate starting in early childhood. Deletions that remove whole exons but keep the reading frame intact tend to cause Becker: the protein is shorter than normal but still partially functional, and muscle decline is slower and less severe.12PubMed Central. The molecular basis for Duchenne versus Becker muscular dystrophy: correlation of severity with type of deletion
This “reading frame rule” correctly predicts the clinical outcome in the large majority of cases. One study found a diagnostic agreement rate of about 85%, and combining the reading frame prediction with clinical milestones pushed accuracy above 93%.13PubMed Central. Walking alone milestone combined reading-frame rule improves early prediction of Duchenne muscular dystrophy The exceptions are informative: some BMD patients carry deletions that should shift the frame, suggesting their cells manage to restart translation from an internal starting point downstream of the deletion, rescuing enough protein to soften the disease.14PubMed. Frame-shift deletions in patients with Duchenne and Becker muscular dystrophy These exceptions helped inspire a therapeutic strategy described below.
Frameshifts in Hereditary Cancer
Several of the best-known cancer predisposition genes are inactivated by frameshift mutations. BRCA1, linked to hereditary breast and ovarian cancer, and APC, linked to familial adenomatous polyposis and colorectal cancer, both frequently harbor truncating mutations that create premature stop codons. Screening methods have long exploited this fact, using assays that specifically detect truncated proteins to identify carriers.15PubMed. Detection of heterozygous truncating mutations in the BRCA1 and APC genes by using a rapid screening assay in yeast In rare cases, a single patient may inherit frameshift mutations in both genes simultaneously: one report documented a patient with coinherited APC and BRCA1 frameshift mutations who developed colorectal cancer, underscoring the cumulative burden that multiple truncating mutations can place on cancer defense.16PubMed Central. Case Report: Coinheritance of Germline Mutations in APC and BRCA1 in Colorectal Cancer
These hereditary frameshifts are germline events, meaning a person is born with them in every cell. But frameshifts also accumulate somatically during a person’s lifetime, especially in tumors with defective mismatch repair. The resulting explosion of frameshift mutations across the cancer genome turns out to have a surprising silver lining for treatment, which has reshaped thinking in immunotherapy.
Frameshift Neoantigens and Immunotherapy
When mismatch repair fails in a tumor, frameshift mutations pile up at microsatellite sequences throughout the genome. The garbled proteins these frameshifts produce are genuinely foreign to the immune system, creating novel peptide fragments called neoantigens that immune cells can potentially recognize and attack. Researchers analyzing microsatellite-unstable colorectal, endometrial, and stomach cancers found that certain genes are frameshifted so commonly that the resulting peptides are shared across large fractions of patients. In microsatellite-unstable colorectal tumors, certain shared frameshift-derived immune targets appeared in up to 60% of patients.17Cell. Shared neoantigens arising from frameshift mutations in microsatellite unstable cancers
This sharing matters because it opens the door to off-the-shelf vaccines or T-cell therapies that do not need to be custom-built for each patient. Separate work confirmed that the load of frameshift-derived insertions and deletions in microsatellite-unstable cancers is high and that multiple concurrent frameshifts per tumor are the norm, generating a rich landscape of potential immune targets.18Nature Communications. The shared frameshift mutation landscape of microsatellite-unstable cancers suggests immunoediting during tumor evolution This biology helps explain why tumors with high microsatellite instability respond unusually well to checkpoint immunotherapy drugs, which release the brakes on immune cells. The frameshifts provide the targets; the drugs provide the permission for the immune system to attack.
Exon-Skipping Therapy for Duchenne
If a frameshift mutation is what turns a manageable Becker phenotype into severe Duchenne, then fixing the reading frame should convert Duchenne back toward Becker. That is the principle behind exon-skipping therapy. Short synthetic molecules called antisense oligonucleotides bind to a specific region of the pre-mRNA and trick the cell’s splicing machinery into removing a targeted exon. By skipping the right exon, the reading frame is restored, and the cell produces a shortened but partially functional dystrophin protein instead of none at all.19PubMed Central. Antisense Oligonucleotide-Mediated Exon-skipping Therapies: Precision Medicine Spreading from Duchenne Muscular Dystrophy
This approach has been validated in animal models, including mice and dogs carrying dystrophin mutations, where antisense oligonucleotides successfully induced exon skipping and restored dystrophin expression.20PubMed. Effective exon skipping and restoration of dystrophin expression by peptide nucleic acid antisense oligonucleotides in mdx mice21PubMed. Antisense oligonucleotide-induced exon skipping restores dystrophin expression in vitro in a canine model of DMD Several exon-skipping drugs have since received regulatory approval for human use, targeting different exons depending on where the patient’s deletion lies. The strategy is genuinely personalized: a drug that skips exon 51 helps patients whose deletions are corrected by removing that exon, but does nothing for patients whose frameshifts lie elsewhere. This has driven development of multiple exon-specific drugs, though collectively they still only cover a portion of all DMD mutations.
CRISPR and Unintended Frameshifts
Gene editing with CRISPR-Cas9 relies on the cell’s own repair systems to patch the cuts it introduces. The most common repair pathway, non-homologous end joining, frequently produces small insertions or deletions at the cut site. When researchers aim to knock out a gene, they count on these edits to create a frameshift and a premature stop codon, triggering nonsense-mediated decay and silencing the gene.22PubMed Central. CRISPR-Cas9-based mutagenesis frequently provokes on-target mRNA misregulation In many experiments, this works as planned.
But it does not always work cleanly. Researchers have found that some frameshift alleles created by CRISPR still produce protein through unexpected mechanisms, including translation initiation from internal start sites downstream of the edit. In one study targeting the Gli3 gene, multiple biallelic frameshift cell lines were generated, yet not all behaved as true knockouts, with some expressing truncated proteins from alternative reading frames.23Scientific Reports. Illegitimate translation causes unexpected gene expression from on-target out-of-frame alleles created by CRISPR-Cas9 These findings complicate the assumption that a frameshift automatically equals gene knockout. For research labs designing experiments and, increasingly, for clinical gene-therapy applications, verifying that the intended frameshift truly silences the target has become a critical quality-control step.
Programmed Frameshifting in Viruses
Not all frameshifts are mistakes. Many viruses deliberately exploit ribosomal frameshifting as part of their replication strategy. At carefully engineered sequence signals in the viral RNA, the ribosome is induced to slip backward by one nucleotide at high frequency, entering a new reading frame and producing a different protein. This allows a single stretch of RNA to encode two overlapping proteins, with the ratio between them controlled by how efficiently the ribosome slips.24PubMed Central. Structural and Functional Insights into Viral Programmed Ribosomal Frameshifting The mechanism is found across hundreds of RNA virus families.
SARS-CoV-2 brought this biology into sharp focus. The virus depends on programmed frameshifting to produce the RNA-dependent RNA polymerase it needs to copy its genome.25PubMed Central. Structural basis of ribosomal frameshifting during translation of the SARS-CoV-2 RNA genome Without successful frameshifting, the polymerase is never made and the virus cannot replicate. This has made the frameshifting signal an appealing drug target: a small molecule that jams the ribosome’s ability to slip at that site could, in principle, shut down viral replication. Programmed frameshifting is not limited to viruses, either. Bacteria, archaea, and eukaryotes all use it, though generally as a way to downregulate protein production by triggering decay of the frameshifted transcript.26PubMed Central. Regulators of Viral Frameshifting: More Than RNA Influences Translation Events
Bacterial Phase Variation
Some bacteria have turned frameshift mutations into a survival strategy. In stretches of simple sequence repeats within their genomes, slippage occurs at elevated rates, toggling genes on and off with each generation. When a repeat contracts or expands by one unit, the downstream gene shifts in or out of frame, switching expression between functional and nonfunctional states. This rapid-fire variation, called phase variation, helps pathogens dodge the host immune system by constantly shuffling the surface molecules the immune system tries to target.27PubMed. Evolution of simple sequence repeat-mediated phase variation in bacterial genomes
Analysis of hundreds of prokaryotic genomes shows that host-adapted pathogens with small genomes are especially enriched for these short repeat tracts, and that the enrichment is maintained by natural selection rather than occurring by chance.28PubMed Central. Simple sequence repeats in prokaryotic genomes Some species go further, positioning their simple repeats near the beginning of genes, which maximizes the chance that a frameshift will produce a completely nonfunctional protein rather than a partially altered one.29Nucleic Acids Research. Evolutionary pressures on simple sequence repeats in prokaryotic coding regions The result is a clean on/off switch rather than a dial, giving the bacterial population a bet-hedging advantage against unpredictable host defenses.
How Many Frameshifts Does a Healthy Person Carry?
Genome sequencing has revealed something counterintuitive: every apparently healthy person walks around with a substantial load of gene-disrupting variants. A systematic survey estimated that a typical human genome contains about 100 genuine loss-of-function variants, with roughly 20 genes completely knocked out on both copies.30PubMed Central. A systematic survey of loss-of-function variants in human protein-coding genes Frameshifting insertions and deletions make up a significant share of these. Common frameshifts tend to sit in genes that the body can afford to lose, while rare ones are more likely to be damaging: there is a clear inverse relationship between how frequent a frameshifting variant is in the population and how harmful computational tools predict it to be.31PubMed Central. Predicting the effects of frameshifting indels
In rare cases, gene loss through frameshifts has even been beneficial. Comparative analysis of primate genomes shows that some loss-of-function mutations were positively selected during human evolution, contributing to distinctly human traits. This “less is more” hypothesis suggests that losing a gene can sometimes be advantageous if the gene’s product was a net liability in a new environmental context.32PubMed Central. Loss of gene function and evolution of human phenotypes Furthermore, pairs of compensatory frameshifts have been identified in evolutionary lineages: a second insertion or deletion downstream of the first one restores the original reading frame, limiting the damage to a short stretch of garbled protein while preserving function across the rest of the gene.33Molecular Biology and Evolution. Pairs of Mutually Compensatory Frameshifting Mutations Contribute to Protein Evolution
Frameshifted Proteins in Neurodegeneration
One of the more unexpected places frameshift biology has appeared is in Alzheimer’s disease. Researchers found that a frameshifted form of ubiquitin B, a small protein involved in tagging damaged proteins for destruction, accumulates in the characteristic plaques and tangles of Alzheimer’s brains. The frameshifted ubiquitin, called UBB+1, arises not from a DNA mutation but from errors in RNA processing, and it appears to impair the protein-disposal system that neurons rely on to stay healthy.34PubMed Central. Misframed ubiquitin and impaired protein quality control: an early event in Alzheimer’s disease
UBB+1 is not unique to Alzheimer’s. It has been detected in the neural hallmarks of other neurodegenerative conditions, including Huntington’s disease and other tauopathies.35PubMed. Molecular misreading: the occurrence of frameshift proteins in different diseases This suggests a broader role for frameshifted proteins in age-related brain disease, possibly tied to a gradual decline in the fidelity of RNA processing as neurons age. Whether UBB+1 is a cause or a consequence of neurodegeneration remains debated, but its consistent presence across multiple diseases has made it a focus of ongoing research into how protein quality control breaks down in the aging brain.
The 1961 Experiment That Started It All
Frameshift mutations played a starring role in one of the foundational discoveries of molecular biology. In 1961, Francis Crick and Sydney Brenner, working at the Cavendish Laboratory in Cambridge, used frameshift-inducing mutations in bacteriophage to demonstrate that the genetic code is read in groups of three nucleotides.36Natural Sciences. A breakthrough from 60 years ago: “General nature of the genetic code for proteins” (1961) Their reasoning was elegant: a single insertion or deletion knocked out gene function, as expected if the reading frame was disrupted. But combining three insertions (or three deletions) in the same gene often restored function, because the reading frame returned to normal after a short stretch of garbled sequence. This pattern only made sense if the code was read in threes. The experiment did not identify which triplet encoded which amino acid, but it established the triplet principle that made cracking the rest of the code possible. Frameshift mutations were not just a problem to solve; they were the tool that unlocked one of biology’s most fundamental rules.